Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Mymensingh Med J ; 22(1): 143-7, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-23416822

RESUMO

The transfusion of whole blood derived platelets (WBDPs) or apheresis platelets (APs) is standard support for cancer patients. However, disputes remain about which type of platelets are ideal in terms of efficacy, cost, and the risk of adverse reactions. This cross sectional study included 141 cancer patients who underwent chemotherapy or hematopoietic progenitor cell transplantation and received platelet transfusions at The University of Texas M.D. Anderson Cancer Center between 2002 and 2003 were retrospectively evaluated. A total of 141 patients who did not differ significantly in terms of age or sex had a reaction to transfusions (WBDPs, n=123; APs, n=18), for a frequency of 0.66% in patients who received WBDPs and 0.45% in patients who received APs, but this difference was not statistically significant (p=0.13). More WBDP-related reactions occurred in patients transfused with older platelets (>2 days old) than in patients transfused with fresh platelets, but the difference compared with AP-associated reactions was not statistically significant. However, the rate of reactions to WBDP may increase if WBDPs are stored for a prolonged time (>2 days). Until evidence becomes available that clearly refutes this; the more fresh platelets as possible may be used.


Assuntos
Incompatibilidade de Grupos Sanguíneos/etiologia , Transfusão de Plaquetas/efeitos adversos , Plasma Rico em Plaquetas , Plaquetoferese/métodos , Trombocitopenia/terapia , Adolescente , Adulto , Idoso , Antineoplásicos/efeitos adversos , Criança , Estudos Transversais , Feminino , Transplante de Células-Tronco Hematopoéticas/efeitos adversos , Hemorragia/prevenção & controle , Hemorragia/terapia , Humanos , Masculino , Pessoa de Meia-Idade , Razão de Chances , Transfusão de Plaquetas/métodos , Estudos Retrospectivos , Trombocitopenia/etiologia , Fatores de Tempo , Adulto Jovem
2.
Int J Cancer ; 86(1): 128-31, 2000 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-10728606

RESUMO

Oral cancer is the second most common cancer in women and the third most common in men in Pakistan. Tobacco is smoked and chewed extensively in Pakistan. Paan is a quid of piper betel leaf that contains areca nut, lime, condiment, sweeteners, and sometimes tobacco, which is also used extensively. We did this study to clarify the independent association of paan and oral cancer. Between July 1996 and March 1998, we recruited biopsy-proven, primary cases of oral squamous-cell carcinoma, from 3 tertiary teaching centers in Karachi, Pakistan, and controls pair-matched for age, gender, hospital and time of occurrence, excluding persons with a past or present history of any malignancy. There were 79 cases and 149 controls. Approximately 68% of the cases were men, 49 years old on average, the youngest being 22 years old and the eldest 80. People with oral submucous fibrosis were 19.1 times more likely to develop oral cancer than those without it, after adjusting for other risk factors. People using paan without tobacco were 9.9 times, those using paan with tobacco 8.4 times, more likely to develop oral cancer as compared with non-users, after adjustment for other covariates. This study identifies an independent effect of paan without tobacco in the causation of oral cancer. Its findings may be of significance in South Asian communities where paan is used, and among health-care providers who treat persons from South Asia.


Assuntos
Areca/efeitos adversos , Neoplasias Bucais/etiologia , Plantas Medicinais , Adolescente , Adulto , Idoso , Estudos de Casos e Controles , Feminino , Fibrose/epidemiologia , Fibrose/etiologia , Humanos , Masculino , Pessoa de Meia-Idade , Mucosa Bucal/patologia , Neoplasias Bucais/epidemiologia , Paquistão/epidemiologia , Folhas de Planta , Plantas Tóxicas , Fatores de Risco , Tabaco sem Fumaça/efeitos adversos
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA